Sientra is a medical aesthetics company engaged in transformative treatments and technologies focused on progressing the art of plastic surgery. Co. has one operating segment named Plastic Surgery. Co.'s Plastic Surgery segment focuses on sales of its breast implants, tissue expanders, and scar management products. Co.'s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Co.'s breast implants are used in elective augmentation procedures that are generally performed on a cash-pay basis and in non-elective reconstructive procedures for post-mastectomy women that are generally performed on a third-party payor basis. The SIEN average annual return since 2014 is shown above.
The Average Annual Return on the SIEN average annual return since 2014 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SIEN average annual return since 2014 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SIEN average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Free SIEN Email Alerts:
Video: Don't Forget Dividends in Average Annual Return!
